Genetically engineered bacteriocins and their potential as the next generation of antimicrobials

Osnat Gillor1, Lisa M Nigro, Margaret A Riley

  • 1Department of Ecology and Evolutionary Biology, Yale University, New Haven, CT 06511, USA. Osnat.gillor@yale.edu

Insights

Bacteriocins, a class of toxins, show promise as next-generation antimicrobials. Genetic engineering techniques are being used to create custom bacteriocins to combat antibiotic-resistant bacteria.

Area of Science:

  • Microbiology
  • Biotechnology
  • Drug Discovery

Background:

  • The discovery of penicillin marked a milestone in combating infectious diseases, leading to the development of over 100 antibiotics.
  • The rise of antibiotic-resistant pathogens necessitates the development of novel antimicrobial strategies.
  • Bacteriocins, a diverse family of toxins, are being explored as potential next-generation antimicrobials due to their targeted activity.

Purpose of the Study:

  • To review recent efforts in generating custom-designed bacteriocins using genetic engineering.
  • To highlight the potential of genetically-modified bacteriocins in addressing challenges posed by multi-resistant bacteria.

Main Methods:

  • Focus on genetic engineering techniques for bacteriocin design.
  • Review of literature on bacteriocin development and application.

Main Results:

  • Bacteriocins possess a narrow killing spectrum, targeting specific bacterial strains.
  • Genetic modification allows for the creation of custom bacteriocins with tailored activity.
  • These engineered bacteriocins show potential in combating challenging multi-resistant pathogens.

Conclusions:

  • Genetically modified bacteriocins represent a promising approach to overcome antibiotic resistance.
  • The targeted nature of bacteriocins offers a "designer drug" strategy for specific pathogens.
  • Further development of engineered bacteriocins could significantly impact disease control efforts.

Related Concept Videos

Biological Methods for Microbial Control01:28

Biological Methods for Microbial Control

Biological agents offer an effective means of controlling microbial growth by leveraging natural processes like predation, competition, and the secretion of antimicrobial substances.Predatory bacteria such as Bdellovibrio species target and kill pathogens like Salmonella and E. coli. They are widely used in poultry farms to control infections. Myxococcus species help combat plant-pathogenic fungi. These naturally occurring predators serve as eco-friendly alternatives to chemical pesticides and...
Antibiotic Selection00:57

Antibiotic Selection

Overview
Gene Regulation in Microbial Communities: Quorum Sensing01:28

Gene Regulation in Microbial Communities: Quorum Sensing

Quorum sensing is a mechanism of bacterial communication that enables coordinated gene expression in response to changes in population density. This facilitates collective behaviors that enhance survival, resource acquisition, and ecological adaptation. This process relies on small signaling molecules called autoinducers that accumulate as bacterial populations grow. When a critical threshold concentration of autoinducers is reached, bacterial cells collectively modify gene expression,...
Inhibitors of Bacterial Protein Synthesis01:25

Inhibitors of Bacterial Protein Synthesis

Aminoglycosides constitute a highly potent class of bactericidal antibiotics that exert their antimicrobial effects by targeting the bacterial ribosome, specifically disrupting protein synthesis. These polycationic molecules consist of amino-modified sugars linked via glycosidic bonds to an aminocyclitol core such as 2-deoxystreptamine or streptamine. Their strong positive charges facilitate tight binding to the negatively charged phosphate backbone of ribosomal RNA (rRNA), primarily at the 16S...
Clinical Significance of Antibiotic Resistance01:25

Clinical Significance of Antibiotic Resistance

Methicillin-resistant Staphylococcus aureus (MRSA) presents a critical public health threat, arising from its capacity to resist β-lactam antibiotics due to acquisition of the mecA gene within the staphylococcal cassette chromosome mec (SCCmec). This gene encodes penicillin-binding protein 2a (PBP2a), which impairs binding efficacy of methicillin and other β-lactams. MRSA has evolved into distinct clonal lineages impacting humans and animals alike, reinforcing its significance within the One...
CRISPR and crRNAs02:53

CRISPR and crRNAs

Bacteria and archaea are susceptible to viral infections just like eukaryotes; therefore, they have developed a unique adaptive immune system to protect themselves. Clustered regularly interspaced short palindromic repeats and CRISPR-associated proteins (CRISPR-Cas) are present in more than 45% of known bacteria and 90% of known archaea.
The CRISPR-Cas system stores a copy of foreign DNA in the host genome and uses it to identify the foreign DNA upon reinfection. CRISPR-Cas has three different...